Silence Therapeutics plc Total Liabilities and Equity
Silence Therapeutics plc (SLNCF) had Total Liabilities and Equity of $106.41 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-10
- 2026-06-30: Liabilities and Equity $106.41M.
- 2026-03-31: Liabilities and Equity $115.12M.
- 2025-12-31: Liabilities and Equity $131.44M.
- 2025-09-30: Liabilities and Equity $146.79M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $106.41M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $115.12M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $131.44M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $146.79M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $165.23M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $185.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $202.63M 10-K · filed 2026-03-05 |
| 2023-12-31 | $119.45M 10-K · filed 2025-02-27 |